German CRO Proinnovera establishes U.S. foothold in North Carolina

Proinnovera named Sonja VanWye, from nearby Novella Clinical, as vice president of its U.S. clinical operations. (Pixabay)

The German dermatology CRO Proinnovera has opened a new U.S. base of operations through a wholly owned subsidiary based in Wilmington, North Carolina.

Proinnovera said it established an office in the U.S. in response to feedback from clients looking for a specialized global dermatology CRO in the country.

The subsidiary opened for business June 1, offering full-service clinical trial work in dermatology, immunology, inflammatory skin diseases, skin cancer and precancer, burns, wounds and aesthetics.

“We’re seeing the need for global reach of dermatology studies ever increasing. We want to meet this need by offering our clients a global presence with deep and responsive local expertise,” Marion Breuer, who shares the role of CEO with owner Burkhard Breuer, said in a statement.

Headquartered in Münster, Germany, Proinnovera also named Sonja VanWye as vice president of U.S. clinical operations. VanWye will be responsible for general management, team development, vendor selection and expanding the CRO’s footprint in the country.

VanWye was director of clinical operations and head of project management for Novella Clinical, based in the state’s Raleigh-Durham-Chapel Hill research triangle area, which had previously acquired TKL Research’s phase 2-4 clinical trials division to serve as its dermatology unit.